The Food and Drug Administration signed off on vaccines for American children as young as 6-months-old. Now it’s onto the Centers for Disease Control and Prevention for the final green light. Shots could go into arms next week if they’re authorized for emergency use.
A final signoff from the Centers for Disease Control and Prevention is expected this weekend.
The first COVID-19 shots for U.S. infants, toddlers and preschoolers moved a step closer Wednesday.
We’re now learning more information about when the Food and Drug Administration and Abbott Nutrition’s Sturgis plant first found out about a whistle blower’s allegations about quality control concerns within the plant. ABC News confirms both were alerted a year before the recall was issued.
Nephron Pharmaceuticals says it is issuing a voluntary recall of some of its products due to concerns over “lack of assurance of sterility.”
Consumer News: FDA investigating hepatitis A outbreak linked to organic strawberries, gas prices hit new record and more
Pfizer says it is ready to submit its vaccine to the FDA for emergency use authorization for children 6 months to 5 years old, releasing preliminary data about effectiveness.
The head of the FDA is on Capitol Hill answering questions from lawmakers today. This comes as the nation’s largest baby formula factory is poised to reopen.
Vaccine advisers with the CDC are set to vote today on COVID-19 boosters for children ages 5-11.
The resolution to the baby formula shortage can’t come soon enough for many parents. This evening, the FDA and Abbott Nutrition have agreed on a plan to reopen one of their facilities that was shut down due to contamination. The agreement, however, comes with strict guidelines the formula maker must follow.
